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Brief Technique Reportsthereby ensuring adequate lumen diameter with no residual
stenosis.
We applied this technique in 3 patients undergoing car-
diopulmonary resuscitation who required life-saving extra-
corporeal membrane oxygenation support. Initiation of
perfusion was rapid (14 3 minutes from incision to perfu-
sion). Peripheral perfusion was easily detectable with vas-
cular Doppler examination. In one case an inflow/outflow
mismatch was suspected because the limb became slightly
edematous after 12 hours of perfusion. In this case the pros-
thesis was not beveled, resulting in a noncommitted 90
anastomosis. The potentially higher distal flow of this
configuration in combination with the partially occluded
femoral vein (through the venous cannula) could have con-
tributed to this problem, which resolved after decannula-
tion. The other patients did not have any perfusion-related
complications (extracorporeal membrane oxygenation was
discontinued after 74 and 54 hours, respectively).
DISCUSSION
Peripheral ischemia distal to the cannulation site is a se-
vere complication of femoral arterial cannulation for extra-
corporeal life support.1,2 When the patient’s hemodynamic
condition is stable enough, suturing a beveled prosthetic
graft to the artery and placing the distal end of the
cannula at the level of the anastomosis avoids lumen
occlusion by the cannula, thereby preventing any distal
malperfusion.2 In dramatically critical situations rapid initi-
ation of the lifesaving perfusion has first priority. With the
described technique, perfusion can be initiated rapidly.
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the prosthesis allows for a more favorable flow direction to-
ward the heart, potentially avoiding preferential distal flow.
There are also alternative techniques.3-5 Those with
published clinical applications have in common the
introduction of an additional catheter in the distal artery,
which is then connected to the extracorporeal circuit.
These techniques also allow for a rapid initiation of
perfusion. However, the effective distal perfusion flow can
be low because it is determined by the resistance of the
connection of the perfusion catheter to the circuit and of
the diameter of the catheter itself. In addition, after
decannulation, the femoral arteries are left with 2
openings and potential thrombus formation between them,
requiring careful vascular reconstruction.
In summary, we present a rapid femoral arterial cannula-
tion technique for extracorporeal life support, which allows
for unimpaired distal limb perfusion.References
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muscular or residual ventricular septal defectsNorihiko Oka, MD, PhD, Christian P. Brizard, MD, Matthew Liava’a, MBChB, and
Yves d’Udekem, MD, PhD, Melbourne, AustraliaWith conventional pulmonary arterial banding (PAB), a sec-
ond surgical procedure to remove the band is compulsory,
regardless of eventual ventricular septal defect (VSD) closure.
Use of an absorbable PAB abolishes this requirement.1
In 2003, we started to use a custom absorbable PABmade
of polydioxanone, mainly for patients in whom muscular
and residual VSDs were expected to close spontaneously.
Polydioxanone is a widely used biodegradable polymer
that is known to keep 35% of its mechanical strength for
about 3 weeks and to degrade completely in about 6months.
We hypothesized that a PAB made of this absorbablediovascular Surgery c Volume 141, Number 4 1081
FIGURE 1. Evolution of pulmonary arterial gradient after pulmonary ar-
terial banding with an absorbable polydioxanone band.
Brief Technique Reportsmaterial would maintain an adequate pressure gradient long
enough for the muscular or residual VSD to close spontane-
ously, and that the band would then degrade, allowing the
pulmonary artery to grow and expand without the need
for reintervention.
MATERIALS AND METHODS
Between 2003 and 2008, at the Royal Children’s Hospital inMelbourne,
Australia, 15 patients with a median age of 1.2 months (interquartile range,
0.4–2.8 months) underwent 16 PAB procedures with absorbable polydiox-
anone bands. One patient required a reoperative PAB procedure before the
successful spontaneous closure of his muscular VSD was observed. Of
these 15 patients, 2 patients with single-ventricle physiology underwent
PAB for short-term palliation, whereas the remaining 13 patients had resid-
ual VSDs or muscular VSDs expected to close spontaneously. Four of the
13 patients with VSDs had undergone a concomitant coarctation repair, and
2 had undergone repair of an atrioventricular septal defect. Indication for
PAB was concomitant coarctation repair or residual immediate postopera-
tive pulmonary to systemic perfusion ratio greater than 1.5, as calculated
from saturations of the blood collected in the right atrium and the pulmo-
nary artery. Ten patients with VSDs who had follow-up longer than 1 year
constitute the core of this study.
Surgical Technique
A 5-mm wide absorbable PAB was tailored from a polydioxanone tape
(Johnson and Johnson, European Logistics Centre, Sint-Stevens-Woluwe,
Belgium). These polydioxanone tapes are commercially marketed for joint
surgery and are made of flat, woven, absorbable polydioxanone filaments.
The custom PAB was then tightened and secured around the main pulmo-
nary artery with nonabsorbable braided sutures until the distal systolic
pressure fell below 50% of the aortic systolic pressure.
RESULTS
Median follow-up for the 10 patients who had been
followed up for longer than 1 year was 40 months (interquar-
tile range, 30.6–48.5 months). Immediately after surgery, 7
had an adequate gradient increase superior to 40 mm Hg.
For these 7 patients, the median time after which a drop in
the pressure gradient below 30 mm Hg was observed was
7.9 months (interquartile range, 5–11 months; Figure 1).
Three patients had low pressure gradients across the PAB
(18, 23, and 31mmHg). One patient, despite an initial gradi-
ent of 54mmHg, eventually required surgical VSD closure 6
months after PAB. None of the remaining 9 patients required
additional surgical or catheter VSD closure. At the last echo-
cardiographic follow-up, after a median of 14.4 months (in-
terquartile range, 12–22 months), there were no more
pulmonary obstructions at the level of the PAB and no signif-
icant residual VSDs. The mean pulmonary arterial gradient
was 4.7 5.1mmHg. The narrowingwas no longer reported.
DISCUSSION
In 1991 and 1992, the first few clinical trials of absorb-
able PABs were reported.2,3 Bonnet and colleagues4 de-
scribed a series of patients who underwent surgicaltreatment of aortic coarctation with VSD by placement of
an absorbable PAB. They were able to avoid subsequent
cardiac surgery in 91% of cases. We recently reported the
usefulness of this adjunct technique after surgical repair
of complex multiple VSDs.5 Our study confirms that PAB
with an absorbable polydioxanone band is a useful strategy
for VSDs that are expected to close. Once the absorbable
band starts to lose its strength, presumably around 6 postop-
erative months, the main pulmonary artery is free to expand
and grow. Becausewe do not schedule follow-up echocardi-
ography more often than every 3 months, it is difficult to
know exactly when the band loses its function. It seems,
however, that the absorbable band eventually dissolves
and does not leave any stenosis. In our series, the time nec-
essary to achieve dissolution of the band was sufficient to
allow spontaneous VSD closure in all but 1 case. Nine of
10 patients avoided reoperation for band removal.
In conclusion, PAB with an absorbable polydioxanone
band is often a successful strategy for patients with muscu-
lar or residual VSDs that are expected to close spontane-
ously, because it avoids the need for a second reoperation
to remove the band.References
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